ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Appropriateness of prescribing alfacalcidol in secondary hyperparathyroidism in dialysis patients: a retrospective study
About authors
1 College of Pharmacy, University of Thi-Qar, Thi-Qar, Iraq
2 College of Pharmacy, Al-Ayen Iraqi University, AUIQ, An Nasiriyah, Iraq
Correspondence should be addressed: Fatma M. Mostafa
Thi-Qar, 64001, Iraq; moc.liamg@999888afatsomamtaf
About paper
Acknowledgements: the authors would like to thank the staff and administration of the hemodialysis units in An-Naseria, Iraq, for their cooperation and support in accessing patient records. The authors also express gratitude to the College of Pharmacy, University of Thi-Qar, and Al-Ayen Iraqi University for providing logistical support.
Author contribution: Fatma M. Mostafa — conceptualization, study design, data collection, data analysis, manuscript drafting, and final approval; Sarah Jaafar Saadoon — data collection, visualization, review, and manuscript revision; Ammar Mohammed Atiyah — data interpretation, statistical analysis (SPSS), and critical revision of the manuscript; Ahmed H. Ibrahim — data validation, manuscript editing, and final approval.
Compliance with ethical standards: this retrospective study was conducted in accordance with the ethical standards, the research was approved by the Research Ethics Committee of Al-Ayen Iraqi University under approval number AUIQ-REC-2025-003. Due to the retrospective nature of this study using anonymized patient records, the requirement for informed consent was waived by the ethics committee.
Received: 2026-04-13
Accepted: 2026-05-16
Published online: 2026-05-30
|
Table 1. Demographic data & biochemical factors of secondary hyperparathyroidism patients
Table 2. Biochemical and dialysis variables in vitamin D indicated and non-indicated patients
Table 3. PTH level (pg/ml) in association with vitamin D indicated and not-indicated patients
Note: Chi-square test was utilized; * — P-value is significant.
Table 4. Corrected calcium level (mmol/l) in association with vitamin D indicated and not-indicated patients
Note: Chi-square test was utilized.
Table 5. Phosphorus level (mg/dl) in association with vitamin D indicated and not-indicated patients
Note: Chi-square test was utilized.
